Premium
IBRUTINIB IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: REAL LIFE DATA FROM THE 'RETE EMATOLOGICA DEL LAZIO PER I LINFOMI' (RELLI)
Author(s) -
Mariani S,
Pelliccia S,
Bianchi M. P,
Di Rocco A,
Petrucci L,
Maiolo E,
Battistini R,
Fanelli F,
Tomei G,
Palombi F,
Papa E,
Pupo L,
Andriani A,
Hoaus S,
Cantonetti M,
Tesei C,
Tafuri A
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.32_2881
Subject(s) - ibrutinib , medicine , mantle cell lymphoma , bendamustine , bruton's tyrosine kinase , chop , refractory (planetary science) , gastroenterology , blastoid , progression free survival , surgery , lymphoma , oncology , chemotherapy , rituximab , tyrosine kinase , leukemia , chronic lymphocytic leukemia , astrobiology , physics , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom